Clinical Implications of HCV Resistance This program is supported by an educational grant from Clinical Implications of HCV Resistance clinicaloptions.com/hepatitis About…

Slide 1 Carlo Cammà Cattedra di Gastroenterologia Università di Palermo [email protected] Roma 25 Novembre 2010 Il management del paziente difficile nelle infezioni…

1. 18 Dicembre 2012Inibitori delle proteasi di HCVdi I generazione: sono una reale innovazione?Antonio CraxìGastroenterologia & Epatologia,Di.Bi.M.I.S. Università di…

Slide 1 Squire, Sanders & Dempsey L.L.P. www.ssd.com Roadmap to Emerging Regions: Clinical Trials in Developing Countries International Clinical Trials Conference New…

INTRODUCTORY TALK D Costagliola Chapter 1 THE CURRENT DEBATE ON ABACAVIR Summary of studies on the association between exposure to abacavir the risk of myocardial infarction…

Introduction Changes in CD4+ cells miRNA expression following exposure to HIV-1 Claudio Casoli University of Milan Rationale There is evidence that miRNAs can modulate host…

A Harborside Press Publication Editor-in-Chief, James O. Armitage, MD ASCOPost.com VOLUME 1, ISSUE 3 AUGUST 2010 By Richard J. Boxer, MD Physician as Patient: A Personal…

Future therapies Massimo Levrero Department of Internal Medicine - DMISM LEA INSERM U785 Life-Nanoscience Laboratory for Functional Genomics Sapienza University - Rome Potential…